The Wayback Machine - https://web.archive.org/web/20120224000154/https://en.wikipedia.org/wiki/4-Methamphetamine

4-Methylamphetamine

From Wikipedia, the free encyclopedia
  (Redirected from 4-Methamphetamine)
Jump to: navigation, search
4-Methylamphetamine
Systematic (IUPAC) name
1-(4-methylphenyl)propan-2-amine
Clinical data
Pregnancy cat.  ?
Legal status  ?
Identifiers
CAS number 22683-78-9 YesY
ATC code None
PubChem CID 199116
ChemSpider 172349 YesY
ChEMBL CHEMBL166183 YesY
Chemical data
Formula C10H15N 
Mol. mass 149.23 g/mol
SMILES eMolecules & PubChem
 YesY(what is this?)  (verify)

4-Methylamphetamine (4-MA; PAL-313; Aptrol ; p-TAP) is a stimulant and anorectic drug of the phenethylamine and amphetamine chemical classes.

In vitro, it acts as a potent and balanced serotonin, norepinephrine, and dopamine releasing agent with Ki affinity values of 53.4nM, 22.2nM, and 44.1nM at the serotonin, norepinephrine, and dopamine transporters, respectively.[1] However, more recent in vivo studies that involved performing microdialysis on rats showed a different trend. These studies showed that 4-methylamphetamine is much more potent at elevating serotonin (~18 x baseline) relative to dopamine (~5 x baseline). The authors speculated that this is because 5-HT release dampens DA release through some mechanism. For example, it was suggested that a possible cause for this could be activation of 5HT2C receptors since this is known to inhibit DA release. In addition there are alternative explanations such as 5-HT release then going on to encourage GABA release, which has an inhibitory effect on DA neurons.[2]

4-MA was investigated as an appetite suppressant in 1952 and was even given a trade name, but development was apparently never completed.[3] More recently it has been reported as a novel designer drug.[4]

In animal studies, 4-MA was shown to have the lowest rate of self-administration out of a range of similar drugs tested (the others being 3-methylamphetamine, 4-fluoroamphetamine, and 3-fluoroamphetamine), likely as a result of having the highest potency for releasing serotonin relative to dopamine.[5][6]

[edit] See also

[edit] References

  1. ^ Wee, S.; Anderson, KG; Baumann, MH; Rothman, RB; Blough, BE; Woolverton, WL (2004). "Relationship between the Serotonergic Activity and Reinforcing Effects of a Series of Amphetamine Analogs". Journal of Pharmacology and Experimental Therapeutics 313 (2): 848–854. doi:10.1124/jpet.104.080101. PMID 15677348.  edit
  2. ^ Di Giovanni, Giuseppe; Esposito, Ennio; Di Matteo, Vincenzo (2010). "Role of Serotonin in Central Dopamine Dysfunction". CNS Neuroscience & Therapeutics 16 (3): 179–194. doi:10.1111/j.1755-5949.2010.00135.x. PMID 20557570.  edit
  3. ^ Gelvin, EP; McGavack, TH (1952). "2-Amino-1-(p-methylphenyl)-propane (aptrol) as an anorexigenic agent in weight reduction". New York state journal of medicine 52 (2): 223–6. PMID 14890975.  edit
  4. ^ 4-Methylamphetamine alert by EMCDDA
  5. ^ Wee, S; Anderson, KG; Baumann, MH; Rothman, RB; Blough, BE; Woolverton, WL (2005). "Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs.". The Journal of pharmacology and experimental therapeutics 313 (2): 848–54. doi:10.1124/jpet.104.080101. PMID 15677348. 
  6. ^ Baumann MH, Clark RD, Woolverton WL, Wee S, Blough BE, Rothman RB. In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the rat. Journal of Pharmacology and Experimental Therapeutics. 2011 Apr;337(1):218-25. PMID 21228061
Personal tools
Namespaces
Variants
Actions
Navigation
Interaction
Toolbox
Print/export
Morty Proxy This is a proxified and sanitized view of the page, visit original site.